715
Views
3
CrossRef citations to date
0
Altmetric
Commentaries

Crucial requirement for standardization during the development of novel recombinant BCG vaccines: Does the corresponding substrain background matter?

Pages 3099-3102 | Received 23 Jun 2016, Accepted 06 Jul 2016, Published online: 14 Nov 2016

References

  • Behr MA, Small PM. A historical and molecular phylogeny of BCG strains. Vaccine 1999 Feb 26; 17(7–8):915-22; PMID:10067698; http://dx.doi.org/10.1016/S0264-410X(98)00277-1
  • Chen JM, Alexander DC, Behr MA, Liu J. Mycobacterium bovis BCG vaccines exhibit defects in alanine and serine catabolism. Infect Immun 2003 Feb; 71(2):708-16; PMID:12540549; http://dx.doi.org/10.1128/IAI.71.2.708-716.2003
  • Smith D, Wiegeshaus E, Balasubramanian V. An analysis of some hypotheses related to the Chingelput bacille Calmette-Guerin trial. Clin Infect Dis 2000 31:S77-S80; PMID:11010828; http://dx.doi.org/10.1086/314073
  • Brosch R, Gordon SV, Billault A, Garnier T, Eiglmeier K, Soravito C, Barrell BG, Cole ST. Use of a Mycobacterium tuberculosis H37Rv bacterial artificial chromosome library for genome mapping, sequencing, and comparative genomics. Infect Immun 1998 May; 66(5):2221-9; PMID:9573111
  • Antas PR, Castello-Branco LR. New vaccines against tuberculosis: lessons learned from BCG immunisation in Brazil. Trans R Soc Trop Med Hyg 2008 Jul; 102(7):628-30; PMID:18440575; http://dx.doi.org/10.1016/j.trstmh.2008.03.014
  • da Costa C, Walker B, Bonavia A. Tuberculosis vaccines-state of the art, and novel approaches to vaccine development. Int J Infect Dis 2015 Mar; 32:5-12; PMID:25809749; http://dx.doi.org/10.1016/j.ijid.2014.11.026
  • Clark SO, Kelly DL, Badell E, Castello-Branco LR, Aldwell F, Winter N, Lewis DJ, Marsh PD. Oral delivery of BCG Moreau Rio de Janeiro gives equivalent protection against tuberculosis but with reduced pathology compared to parenteral BCG Danish vaccination. Vaccine 2010 Oct 8; 28(43):7109-16; PMID:20708695; http://dx.doi.org/10.1016/j.vaccine.2010.07.087
  • Chen JM, Alexander DC, Behr MA, Liu J. Mycobacterium bovis BCG vaccines exhibit defects in alanine and serine catabolism. Infect Immun 2003 Feb; 71(2):708-16; PMID:12540549; http://dx.doi.org/10.1128/IAI.71.2.708-716.2003
  • Saikolappan S, Estrella J, Sasindran SJ, Khan A, Armitige LY, Jagannath C, Dhandayuthapani S. The fbpA/sapM double knock out strain of Mycobacterium tuberculosis is highly attenuated and immunogenic in macrophages. PLoS One 2012; 7(5):e36198; PMID:22574140; http://dx.doi.org/10.1371/journal.pone.0036198
  • Lotte A, Wasz-Hockert O, Poisson N, Dumitrescu N, Verron M, Couvet E. BCG complications. Estimates of the risks among vaccinated subjects and statistical analysis of their main characteristics. Adv Tuberc Res 1984; 21:107-93; PMID:6475644
  • Lee WI, Huang JL, Yeh KW, Jaing TH, Lin TY, Huang YC, Chiu CH. Immune defects in active mycobacterial diseases in patients with primary immunodeficiency diseases (PIDs). J Formos Med Assoc 2011 Dec; 110(12):750-8; PMID:22248828; http://dx.doi.org/10.1016/j.jfma.2011.11.004
  • Bunch-Christensen K, Ladefoged A, Guld J. The virulence of some strains of BCG for golden hamsters. Further studies. Bull World Health Organ 1970; 43:65-70; PMID:4921093

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.